Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Institut Jerome Lejeune
- Trial code
- NCT05767203
- Record updated
- 14 March 2023
- Original description
Analyze genetic and biological markers in patients with Intellectual Deficiencies (ID) of genetic origin in order to better understand the mechanisms of modified genes, cellular mechanisms, pathways involved in different disorders , complications and pathologies associated with ID of genetic origin.Read full original descriptionShow less
Search for Genetic Markers and Biomarkers to Follow Patients With Intellectual Disabilities of Genetic Origin and to Understand Its Origin and Associated Comorbidities
Analyze genetic and biological markers in patients with Intellectual Deficiencies (ID) of genetic origin in order to better understand the mechanisms of modified genes, cellular mechanisms, pathways involved in different disorders , complications and pathologies associated with ID of genetic origin.
Inclusion: Patient diagnosed with an intellectual disability of genetic origin; Patient of all ages coming for consultation at the Institut Jérôme Lejeune; Patient whose parents or legal representative have received and understood the information document and signed the informed consent for a sample for the research project; Patient affiliated to a social security scheme.
Exclusion: Parents unable to find out about the constraints related to the study; Refusal of informed patient participation; Pregnant, parturient and nursing mothers; Persons deprived of their liberty by judicial or administrative decision.